AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Safety update on paediatric use of oseltamivir.(Regulatory Action and News)
European Union -- A potential influenza pandemic remains currently of high public interest and the European Medicines Agency (EMEA) has provided a safety update on oseltamivir (Tamiflu[R]) see page 274).
Oseltamivir is an antiviral approved in the European Union for the treatment of influenza in children between 1 and 13 years of age and for the prevention and treatment of influenza in adolescents over 13 years and adults.
Two cases of alleged 'suicide' associated with treatment of influenza (involving a 17-year-old boy in February 2004 and a 14-year-old boy in February 2005) were reported to the EMEA. In both cases the adolescents exhibited abnormal/ …
-
- CzechRep to buy further 600,000 packages of Tamiflu.
-
News wire article from: Europe Intelligence Wire
October 14, 2005
700+ words
-
- Suicides linked to Tamiflu - so is only weapon against bird flu safe?
-
News wire article from: Chemical Business Newsbase
November 15, 2005
700+ words
-
- EU's CHMP says Roche's Tamiflu does not pose risk.
-
News wire article from: Europe Intelligence Wire
November 17, 2006
700+ words
-
- Chimie Hebdo: Roche gets EU approval for Pegasys and Tamiflu.
-
News wire article from: Asia Africa Intelligence Wire
March 25, 2002
700+ words
-
- Press Release: Roche receives positive recommendation in Europe for Tamiflu.
-
News wire article from: Chemical Business Newsbase
March 21, 2002
700+ words
